Does VA Cover Dexcom G7 CGM for Patients?

dexcom g7

Dexcom G7 can help Veterans
manage their diabetes
with confidence

Prescribe the #1 recommended CGM brand for your VA patients^1,2

An easier way to manage diabetes is now available for VA patients^*

The Dexcom G7 Continuous Glucose Monitoring (CGM) System allows your patients to see their glucose levels 24/7 without the hassle of fingersticks.^† It uses a small wearable sensor to send glucose numbers to a smartphone^‡ or handheld display device in real time.

This powerful tool can help patients living with all types of diabetes see the impact of food, activity, and medication on their glucose levels so they can make better decisions in the moment. Dexcom G7 is available for qualifying VA patients.*

^†Fingersticks required for diabetes treatment decisions if
symptoms or expectations do not match readings.
^‡Smart device sold separately.

dexcom g7

See how Dexcom G7 changed a Veteran’s life

The most accurate CGM system³

For confident therapy decisions that lead to proven results^4-8

most accurate cgm

INDUSTRY-LEADING MARD^§

The lower the MARD, the better. Dexcom G7 has an 8.2% MARD for adults⁹ compared to 8.9% for FreeStyle Libre 3.¹⁰

CLINICALLY PROVEN RESULTS

Dexcom G7 is proven to lower A1C, increase time in range, and reduce hyper- and hypoglycemia.^4-8

SUPPORTS GREATER PEACE OF MIND

It can notify patients when they are high and before they go too low, helping them stay on track day and night.

The simple CGM system

For easier diabetes management that leads to better treatment adherence.^||,3

all in one sensor

The all-in-one sensor is easy to apply with the push of a button⁹

96% say it's easy to use

96% of surveyed Dexcom G7 customers say it’s easy to use³

#1 customer satisfaction

Dexcom customers are 3x more likely to recommend Dexcom than other CGM brands^¶,11

VA eligibility criteria*

Providers prescribing CGM devices for Veterans must confirm and document the Veteran has been diagnosed with diabetes and is being treated with daily insulin. Veterans taking insulin daily are eligible for a CGM device. It is recommended that CGM be considered under the following circumstances:

	The Veteran requires daily insulin to achieve desired glycemic management targets and/or avoid hypoglycemia based on shared decision-making, as recommended by the VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus.
	The Veteran has an uncommon condition in which hypoglycemia is a significant concern (for example, post-gastrectomy, paraneoplastic syndromes, and reactive hypoglycemia). These Veterans may be considered on a case-by-case basis by the endocrinology subject matter expert at the VISN or facility.
	It is documented that the Veteran has the knowledge and skill set necessary to successfully utilize CGMs, including an understanding of the need to do self-monitoring blood glucose (SMBG) for calibration as recommended by the manufacturer, and to evaluate “high” or “low” blood glucose results or trends based upon readings and/or alarms as recommended by the FDA and the treating healthcare team.
	It is documented that the Veteran has followed provider recommendations for SMBG and therapy changes. This will assist providers with determining potential adherence with CGMs, which is essential in achieving improved outcomes.
	The Veteran agrees to ongoing medical appointments with the multidisciplinary team at least every 6 months (more frequently as recommended) to assess the adherence and benefit derived from CGMs, which will be documented in the medical record and used for justification for continued use.

dexcom veteran and daughter

Our CGM portfolio can help
patients with all types of diabetes
better manage their glucose^2-6

^{The Dexcom CGM portfolio is an expanding line of CGM systems that support a broad range of people with diabetes. Now you can simply prescribe the CGM system that works best for each patient’s individual needs.}

DEXCOM G7 CGM FOR PERSONAL USE

An intuitive user experience with the advanced accuracy that only Dexcom offers

Learn More

DEXCOM G6 CGM FOR PERSONAL USE

Industry-leading connectivity with pumps and pens for powerful integrated diabetes control

Learn More

what to prescribe

Dexcom G7

10-day sensor

NRC CODE: 08627-0077-01 | Fill 3 boxes (1 sensor per box, refill every 30 days)

Receiver (optional)^†

NRC CODE: 08627-0078-01 | Fill 1 (Refill every year)

Image
Dexcom G6

Dexcom G6 Sensor

NRC CODE: 08627-0053-03 |   Dispense 1 (12 refills)

Dexcom G6 Receiver

NRC CODE: 08627-0091-11 |   Dispense 1 (0 refills)

Dexcom G6 Transmitter

NRC CODE: 08627-0016-01 |   Dispense 1 (4 refills)

Image

Request a meeting with a Federal Business Manager

A Dexcom Federal Business Manager will reach out to set up a virtual or in-person meeting to answer your questions.

Request a meeting

*For a complete description of Veterans Affairs coverage criteria and additional information, please see the Department of Veterans Affairs (VA) Updated Guidance on Patient Selection Criteria for Continuous Glucose Monitoring Systems (CGMs), June 30, 2022. A patient must be seen at a VA healthcare facility or a VA Community Care Network clinic to be eligible to receive coverage. ‡Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. §MARD stands for “mean absolute relative difference.” ||Based on use out of 30 days. ¶Based on a comparison of NPS scores among major CGM brands. #Receiver required for Medicare beneficiaries.

1 dQ&A US Q1 2023 US Diabetes Connections Patient Panel Report. 2023; 93-94. 2 Seagrove HCP Survey Q2 2022; 23. 3 Dexcom, data on file, 2022. 4 Beck RW, et al. JAMA. 2017;317(4):371-378. 5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 6 Martens T, et al. JAMA. 2021;325(22):2262-2272. 7 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 8 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 9 Dexcom G7 CGM System User Guide. 2023. 10 FreeStyle Libre 3 Quick Start Guide. Abbott Diabetes Care Inc.; 2022. 11 DQ&A Q1 2023 Patient Perspectives.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider's NPI

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.

Dexcom G7 can help Veteransmanage their diabeteswith confidence

An easier way to manage diabetes is now available for VA patients*